PATENT CLAIM ANALYSIS

Application Number: 15511428
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-05
Patent Classification: ["424", "449000"]

Abstract:
Disclosed herein are compositions that are useful in effecting the transdermal delivery of active agents such as opipramol. More particularly, the disclosed transdermal compositions include an active agent; one or more plasticizers; one or more penetration enhancers; a pressure-sensitive adhesive; and may include one or more hydrophilic polymers.

Claim (Index 37):
The transdermal drug composition of  claim 1 , wherein:\n the plasticizer is 2-(2-ethoxyethoxy)ethanol and comprises about 20% w/w of the composition, or is oleyl alcohol and comprises about 10% w/w of the composition; the penetration enhancer optionally comprises up to about 5% w/w oleic acid and up to about 10% w/w IPM; and the PSA comprises about 59% to about 85% w/w of the composition.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 88.0
- Lexical Diversity: 1.41026
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13885512', '14539824', '15027905', '13501500', '14550514']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7562382109786073
- 35 USC 102 Novelty (BERT): 0.523766178243128
- Combined Prediction Score: 0.7329910077050594
- Mean Citation Score: 249.108906
- Max Citation Score: 313.2574
- Similarity Product: 230.95240711936955

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test